Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sam Keeping

7PUBLICATIONS

18CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 19, 2026

Randomized Controlled Trials Comparing the Standard of Care to Alternative Treatments in Patients with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma: A Systematic Literature Review.

|Sep 25, 2025

Meta-analysis to Investigate the Correlation Between Event-Free Survival and Overall Survival in Patients with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma.

Dandan Zheng, Ali Mojebi, Yuexin Tang

|Apr 24, 2025

Pembrolizumab with Carboplatin and Paclitaxel Versus Alternative Systemic Treatments Recommended for the First-Line Treatment of Recurrent/Metastatic Head and Neck Cancer: An Indirect Treatment Comparison.

Marcin Dzienis, Ali Mojebi, Sam Keeping

|Oct 16, 2023

Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma.

Georg Hess, Martin Dreyling, Lucie Oberic

|Oct 18, 2022

Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.

Georg Hess, Martin Dreyling, Lucie Oberic

|Sep 01, 2022

Matching-adjusted indirect comparison of axi-cel and liso-cel in relapsed or refractory large B-cell lymphoma.

Olalekan O Oluwole, Jenny M H Chen, Keith Chan

Pageof 2

Frequent Collaborators

3 joint publications

Dandan Zheng

3 joint publications

Ali Mojebi

2 joint publications

Jenny M H Chen

1 joint publications

He Jin

1 joint publications

Mayur Amonkar

1 joint publications

Raquel Aguiar-Ibáñez

1 joint publications

Olalekan O Oluwole

1 joint publications

Julia T Snider

1 joint publications

Frederick L Locke

1 joint publications

Georg Hess

Frequent Collaborators

3 joint publications

Dandan Zheng

3 joint publications

Ali Mojebi

2 joint publications

Jenny M H Chen

1 joint publications

He Jin